One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

inhaled COVID-19 vaccine. The AeroVax study, supported by $8M in funding from the Canadian Institutes of Health Research (CIHR), will test needle-free vaccines developed to provide protection from ...

As of mid-December, only 20.9 percent of adults in the US had received their Covid vaccine. For the flu shot, it’s 41.7 percent. Both figures represent a significant drop-off compared to the 73 ...

After a COVID-19 vaccination, there may be a small bump where the needle was inserted into the skin. This is a common reaction after vaccinations caused by an immune response to the vaccine or the ...

Many vaccines available in the world are administered with a needle, but this isn’t the ... Scientists are developing COVID-19 vaccine which can be administered without needles.

The company has completed Phase I clinical trials for COVID-19 ... HD-MAP vaccine delivery has the potential to overcome challenges faced by traditional needle and syringe delivery of vaccines.

McMaster University has developed an inhaled COVID-19 vaccine and studies are starting phase-two of human trials.

While to date only one COVID-19 DNA-based vaccine has ... and mucosal immune response compared to the same vaccine delivered using traditional needle-and-syringe delivery,” Mr. Hoey said.

Imagine if antibodies, hormones for fertility, proteins like insulin, and vaccines could be swallowed instead of taken by ...

Unfortunately, all the available Covid-19 vaccines rely on injection by needle and syringe. Researchers are working on other ways to give children the vaccine which don’t involve a needle and ...

Sinovac Biotech, a China-based biopharmaceutical company specializing in vaccine development, has been urged by shareholder ...